Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

Clinical trial NCT01798134 · COMPLETED

Trial details

NCT number: NCT01798134
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2012-12-01
Primary completion: 2014-11-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.